Pfizer and BioNTech Provide Update on Omicron Variant
WEBDec 8, 2021 · Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization …
WEBAug 22, 2024 · The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older. The KP.2 adaptation is based on FDA guidance, which stated that KP.2 is the preferred strain for COVID-19 vaccines for the US 2024-2025 fall …
Pfizer and BioNTech Receive Positive CHMP Opinion for
WEB4 days ago · The European Commission (“EC”) will review the CHMP’s recommendation and is expected to make a final decision soon. Following the EC decision, Pfizer and BioNTech’s Omicron KP.2-adapted ...
Effectiveness of Bivalent Boosters against Severe Omicron Infection
WEBJan 25, 2023 · Bivalent boosters provided substantial additional protection against severe omicron infection in persons who had previously been vaccinated or boosted, although the effectiveness waned over...
Pfizer Says Its Booster Offers Strong Protection Against Omicron
WEBDec 8, 2021 · WASHINGTON — Pfizer and BioNTech said Wednesday that laboratory tests suggest a booster shot of their coronavirus vaccine offers significant protection against the fast-spreading Omicron variant...
Pfizer says vaccine booster dose protects against omicron variant
WEBDec 9, 2021 · A Pfizer-BioNTech Covid-19 booster shot appears to provide strong protection against the omicron variant, while the initial two-dose vaccine may be insufficient to prevent infection,...
Pfizer and BioNTech start trials of new Omicron-specific jab - BBC
WEBJan 25, 2022 · Pfizer and BioNTech have started clinical trials of a new Covid vaccine which targets the Omicron variant. The companies plan to test the protection gained from the new vaccine as a booster jab...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron …
WEB4 days ago · Following the EC decision, Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine will ship to European Union (EU) member states that have specifically ordered this formulation.
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 …
WEBJun 25, 2022 · Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; bivalent vaccine candidate exhibited a 9.1 and 10.9-fold increase against Omicron
Pfizer and BioNTech Announce Updated Clinical Data for Omicron …
WEBNov 4, 2022 · Bivalent booster elicited approximately 4-fold higher neutralizing antibody titers against Omicron BA.4/BA.5 sublineages compared to the original COVID-19 vaccine in individuals older than 55 years of age.
Skip to content